Scribd Logo
Upload

Welcome to Scribd!

  • 234 views

    DR - Reddy Lab Ltd. Assignment

    Uploaded by

    Mahesh Verma
    The document contains balance sheet and profit and loss data for Dr. Reddy's Laboratories Ltd. for the years 2012 and 2011. Some key highlights include: - Total shareholders' funds increased from Rs. 67,178 Cr. in 2010 to Rs. 77,834 Cr. in 2012. - Revenue from operations increased from Rs. 67,397 Cr. in 2011 to Rs. 84,340 Cr. in 2012. - Net profit increased substantially from Rs. 3,885 Cr. in 2011 to Rs. 7,906 Cr. in 2012.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as XLSX, PDF, TXT or read online from Scribd

    DR - Reddy Lab Ltd. Assignment

    Uploaded by

    Mahesh Verma
    234 views18 pages
    The document contains balance sheet and profit and loss data for Dr. Reddy's Laboratories Ltd. for the years 2012 and 2011. Some key highlights include: - Total shareholders' funds increased from Rs. 67,178 Cr. in 2010 to Rs. 77,834 Cr. in 2012. - Revenue from operations increased from Rs. 67,397 Cr. in 2011 to Rs. 84,340 Cr. in 2012. - Net profit increased substantially from Rs. 3,885 Cr. in 2011 to Rs. 7,906 Cr. in 2012.

    Original Description:

    Dr.Reddy

    Original Title

    Dr.reddy Lab Ltd. Assignment

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document contains balance sheet and profit and loss data for Dr. Reddy's Laboratories Ltd. for the years 2012 and 2011. Some key highlights include: - Total shareholders' funds increased from Rs. 67,178 Cr. in 2010 to Rs. 77,834 Cr. in 2012. - Revenue from operations increased from Rs. 67,397 Cr. in 2011 to Rs. 84,340 Cr. in 2012. - Net profit increased substantially from Rs. 3,885 Cr. in 2011 to Rs. 7,906 Cr. in 2012.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    234 views18 pages

    DR - Reddy Lab Ltd. Assignment

    Uploaded by

    Mahesh Verma
    The document contains balance sheet and profit and loss data for Dr. Reddy's Laboratories Ltd. for the years 2012 and 2011. Some key highlights include: - Total shareholders' funds increased from Rs. 67,178 Cr. in 2010 to Rs. 77,834 Cr. in 2012. - Revenue from operations increased from Rs. 67,397 Cr. in 2011 to Rs. 84,340 Cr. in 2012. - Net profit increased substantially from Rs. 3,885 Cr. in 2011 to Rs. 7,906 Cr. in 2012.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    of 18

    Balance Sheet - Dr Reddy's Laboratories Ltd ( Rs in Cr.

    )
    Particulars
    EQUITY AND LIABILITIES
    Shareholders funds
    Share capital
    Reserves and surplus
    Total Shareholders Funds

    2012

    2010

    849
    76985
    77834

    848
    66330
    67178

    Non current liabilities


    Long term borrowings
    Deferred tax liabilities, net
    Other long term liabilities
    Long term provisions
    Total debt

    635
    937
    28
    298
    1326

    130
    200
    63
    212
    5605

    Current liabilities
    Short term borrowings
    Trade payables
    Long term loans and advances
    Other current liabilities
    Short term provisions
    Total of current Liabilities

    15828
    7678
    13011
    4214
    40731
    119891

    10204
    7334
    9844
    3241
    30623
    103406

    ASSETS
    Non current assets
    Fixed assets
    Tangible asset
    Intangible assets
    Capital work-in-progress
    Current investment
    Inventories
    Trade receivables
    Cash and bank balances
    Short term loans and advances
    Other current assets
    Total of current assets
    Total

    23355
    515
    4232
    21826
    19666
    15265
    29639
    9191
    8885
    1307
    66253
    119891

    18967
    1
    6176
    22707
    2070
    13267
    19435
    8490
    5298
    677
    49237
    103406

    P & L - Dr Reddy's Laboratories Ltd ( Rs in Cr.)


    Income
    Gross Sales
    Less:- Excise duty
    Net Sales
    Service income
    License fees
    Other operating revenue
    Revenue from operation
    Other income
    Total revenue
    Expenses
    Cost of material consumed
    Purchase of stock-in-trade
    Changes in inventories of finished goods, work-in-progress and stock-in-trade
    Finance costs
    Conversion charges
    Excise duty
    Employee benefits expense
    Research and development
    Other expenses
    Provision for other than temporary diminution in the value of long-term investements
    Total expenses
    Operating Profit
    Interest
    Gross Profit
    Depreciation
    Impairment of goodwill and intangibles
    Profit Before Tax
    Tax
    Fringe Benefit Tax
    Deferred Tax
    Net Profit

    2012

    2011

    81,462
    718
    80,744
    388
    1,315
    1,893
    84,340
    1,417

    66,443
    405
    66,038
    530
    110
    719
    67,397
    818

    85,757

    68,215

    22,773
    3,931
    1,006
    592
    636
    11,381
    614
    6,509
    19,444
    223
    68,225

    17,386
    3,076
    1,048
    505
    534
    8,661
    636
    5,813
    15,124
    1,925
    55,623

    17,532
    933
    16,599
    3,128
    688
    12,783
    4140
    0
    737
    7,906

    12,592
    614
    11,978
    3,011
    0
    8,967
    4275
    0
    807
    3,885

    P & L - Dr Reddy's Laboratories Ltd ( Rs in Cr.)


    Income
    Gross Sales
    Less:- Excise duty
    Net Sales
    Service income
    License fees
    Other operating revenue
    Revenue from operation
    Other income
    Total revenue
    Expenses
    Cost of material consumed
    Purchase of stock-in-trade
    Changes in inventories of finished goods, work-in-progress and stock-in-trade
    Conversion charges
    Excise duty
    Employee benefits expense
    Finance costs
    Research and development
    Other expenses
    Provision for other than temporary diminution in the value of long-term investements
    Total expenses
    Operating Profit
    Interest
    Gross Profit
    Depreciation
    Impairment of goodwill and intangibles
    Profit Before Tax
    Tax
    Fringe Benefit Tax
    Deferred Tax
    Net Profit

    2012
    81462
    718
    80744
    388
    1315
    1893
    =SUM(B5:B8)
    1417

    2011
    66443
    405
    66038
    530
    110
    719
    =SUM(C5:C8)
    818

    85757

    68215

    22773
    3931
    1006
    592
    636
    11381
    614
    6509
    19444
    223
    68225

    17386
    3076
    1048
    505
    534
    8661
    636
    5813
    15124
    1925
    55623

    =B11-B24
    933
    =B26-B27
    3128
    688
    =B28-B29-B30
    4140
    0
    737
    =B31-B32-B33-B34

    =C11-C24
    614
    =C26-C27
    3011
    0
    =C28-C29
    4275
    0
    807
    =C31-C32-C33-C34

    Increase
    =B3-C3
    =B4-C4
    =B5-C5
    =B6-C6
    =B7-C7
    =B8-C8
    =B9-C9
    =B10-C10

    YOY Change %
    =D3/C3
    =D4/C4
    =D5/C5
    =D6/C6
    =D7/C7
    =D8/C8
    =D9/C9
    =D10/C10

    =B11-C11

    =D11/C11

    =B14-C14
    =B15-C15
    =B16-C16
    =B17-C17
    =B18-C18
    =B19-C19
    =B20-C20
    =B21-C21
    =B22-C22
    =B23-C23
    =B24-C24

    =D14/C14
    =D15/C15
    =D16/C16
    =D17/C17
    =D18/C18
    =D19/C19
    =D20/C20
    =D21/C21
    =D22/C22
    =D23/C23
    =D24/C24

    =B26-C26
    =B27-C27
    =B28-C28
    =B29-C29
    =B30-C30
    =B31-C31
    =B32-C32
    =B33-C33
    =B34-C34
    =B35-C35

    =D26/C26
    =D27/C27
    =D28/C28
    =D29/C29
    =D30/C30
    =D31/C31
    =D32/C32
    =D33/C33
    =D34/C34
    =D35/C35

    P & L - Dr Reddy's Laboratories Ltd ( Rs in Cr.)

    Particulars
    Sales Turnover
    Excise Duty
    Net Sales
    Other Income
    Stock Adjustments

    2012
    6780.2
    93.9
    6686.3
    191.9
    104.8

    Total Income

    6599.2

    EXPENDITURE :Raw Materials


    Power & Fuel Cost
    Employee Cost
    Other Manufacturing Expenses
    Selling & Administration Expenses
    Miscellaneous Expenses

    2122.9
    177.5
    831.2
    163.1
    1554.4
    80.3

    Total Expenditure

    4929.4

    Operating Profit
    Interest
    Gross Profit
    Depreciation
    Profit Before Tax
    Tax
    Net Profit

    1861.7
    69.2
    1600.6
    301.1
    1259.2
    346.8
    912.4

    2011
    5285.8
    97.3
    5188.5
    117
    79

    2010
    4469.6
    74
    4395.6
    254
    117.3

    2009
    4080.4
    80.9
    3999.5
    212.2
    64.1

    5384.5

    4766.9

    4275.8

    1749.5
    14436
    702.7
    129.5
    1256.7
    65

    1599.4
    104.1
    516.4
    117.3
    1036.6
    50.6

    1534
    90
    412.5
    105.9
    1117.9
    45.3

    4048

    3424.4

    3305.6

    1219.5
    9.9
    1326.6
    247.9
    1051.5
    158.5
    893.4

    1088.5
    16
    1326.5
    222.4
    1084.7
    238.7
    846.1

    758
    27.4
    942.8
    193.6
    729.4
    168.6
    560.9

    2008
    3428.4
    84.51
    3343.89
    197.29
    93.87
    3635.5

    1347.33
    77.12
    366.28
    130.35
    896.54
    37.44
    2855.06
    582.7
    14.69
    765.3
    161.99
    582.54
    108.88
    475.22

    INCOME :
    Sales Turnover
    Excise Duty
    Net Sales
    Other Income
    Stock Adjustments
    Total Income
    EXPENDITURE :
    Raw Materials
    Power & Fuel Cost
    Employee Cost
    Other Manufacturing Expenses
    Selling and Administration Expenses
    Miscellaneous Expenses
    Total Expenditure
    Operating Profit
    Interest
    Gross Profit
    Depreciation
    Profit Before Tax
    Tax
    Net Profit

    2012
    =B5/$B$11
    =B6/$B$11
    =B7/$B$11
    =B8/$B$11
    =B9/$B$11

    2011
    =C5/$C$11
    =C6/$C$11
    =C7/$C$11
    =C8/$C$11
    =C9/$C$11

    2010
    =D5/$D$11
    =D6/$D$11
    =D7/$D$11
    =D8/$D$11
    =D9/$D$11

    2009
    =E5/$E$11
    =E6/$E$11
    =E7/$E$11
    =E8/$E$11
    =E9/$E$11

    2008
    =F5/$F$11
    =F6/$F$11
    =F7/$F$11
    =F8/$F$11
    =F9/$F$11

    =B11/$B$11

    =C11/$C$11

    =D11/$D$11

    =E11/$E$11

    =F11/$F$11

    =B14/$B$11
    =B15/$B$11
    =B16/$B$11
    =B17/$B$11
    =B18/$B$11
    =B19/$B$11

    =C14/$C$11
    =C15/$C$11
    =C16/$C$11
    =C17/$C$11
    =C18/$C$11
    =C19/$C$11

    =D14/$D$11
    =D15/$D$11
    =D16/$D$11
    =D17/$D$11
    =D18/$D$11
    =D19/$D$11

    =E14/$E$11
    =E15/$E$11
    =E16/$E$11
    =E17/$E$11
    =E18/$E$11
    =E19/$E$11

    =F14/$F$11
    =F15/$F$11
    =F16/$F$11
    =F17/$F$11
    =F18/$F$11
    =F19/$F$11

    =B21/$B$11

    =C21/$C$11

    =D21/$D$11

    =E21/$E$11

    =F21/$F$11

    =B23/$B$11
    =B24/$B$11
    =B25/$B$11
    =B26/$B$11
    =B27/$B$11
    =B28/$B$11
    =B29/$B$11

    =C23/$C$11
    =C24/$C$11
    =C25/$C$11
    =C26/$C$11
    =C27/$C$11
    =C28/$C$11
    =C29/$C$11

    =D23/$D$11
    =D24/$D$11
    =D25/$D$11
    =D26/$D$11
    =D27/$D$11
    =D28/$D$11
    =D29/$D$11

    =E23/$E$11
    =E24/$E$11
    =E25/$E$11
    =E26/$E$11
    =E27/$E$11
    =E28/$E$11
    =E29/$E$11

    =F23/$F$11
    =F24/$F$11
    =F25/$F$11
    =F26/$F$11
    =F27/$F$11
    =F28/$F$11
    =F29/$F$11

    Trend Analysis

    Income Statement
    Total Income
    Operating Expenses
    Net Profit
    Trend Analysis
    Total Income
    Operating Expenses
    Net Profit

    2008
    3635.5
    2855.1
    475.22
    2008
    100%
    100%
    100%

    2009
    4275.8
    3305.6
    560.9
    2009
    118%
    116%
    118%

    2010
    4766.9
    3424.4
    846.1
    2010
    131%
    120%
    178%

    2011
    5384.5
    4048
    893.4
    2011
    148%
    142%
    188%

    2012
    6599.2
    4929.4
    912.4
    2012
    182%
    173%
    192%

    600%

    500%

    400%

    300%

    200%

    100%

    0%

    2008

    2009

    2010

    Net Profit
    Operating Expenses
    Total Income

    2010

    2011

    2012

    Ratio Analysis - Dr.Reddy Laborataries Ltd.


    Profitability Ratios
    Gross Profit Margins

    Gross Profit/Total sales

    EBITDA Margins

    EBIDTA/Total sales

    EBIT Margins

    EBIT/Total sales

    Net Profit Margin

    Net Profit/Total Sales

    Activity Ratios
    Inventory Turnover

    Cost of goods sold/(average inventory)

    Days of Inventory

    365/inventory turnover

    Receivables Turnover

    Sales/(average receivables)

    Days of Sales Outstanding

    365/receivables turnover

    Payables Turnover

    Cost of goods sold/average payables

    Days of Payables

    365/payables turnover

    Working Capital Turnover

    Total sales/ average(current assets- current liabilities)

    Fixed Asset Turnover

    Total sales/average Fixed assets

    Total asset Turnover

    Total sales/average total assets

    Equity Turnover

    Total sales/Average Equity

    Liquidity Ratios
    Current Ratio

    Current assets/current liabilities

    Quick Ratio

    (Cash +Marketable securities+receivables)/Current liabilities

    Cash Ratio

    (Cash+Marketable Securities)/Current Liabilities

    Cash Conversion Cycle (Net Operating Cycle)

    Days of inventory+Days of sales outstanding-days of payables

    Return on Investments
    Return on Assets (ROA)

    Net profit/Average total assets

    Return on Invested Capital (RoIC)

    EBIDT/Average capital invested

    Return on Stockholder's Equity (ROE)

    PAT/Average Equity

    Capital employed
    Debt Ratios
    Debt-to-Capital Ratio

    Debt/(Debt+Networth)

    Debt-to-Equity Ratio

    Debt/Networth

    Coverage Ratios
    Interest Coverage Ratio

    EBIT/interest

    Debt Service Coverage Ratio


    Earning per share

    Net Profit/Equity

    94%

    93%

    20%

    18%

    16%

    14%

    9%

    6%

    1.9

    1.6

    187.9

    225.1

    2.7

    3.4

    134.0

    107.4

    3.7

    3.8

    98.9

    96.6

    1.40

    1.34

    0.58

    1.02

    0.77

    1.32

    1.1

    0.98

    0.55

    0.48

    0.88

    0.54

    0.74

    0.44

    223.03

    235.94

    0.07
    #REF!

    0.08
    #REF!

    0.11

    0.06

    77834

    67178

    0.02

    0.08

    0.02

    0.08

    3129

    3012

    0.10

    0.06

    Dupont Anaylsis

    Net Profit Margin


    Asset Turnover Ratio
    Equity Multiplier

    9%
    1.32
    1.54

    6%
    1.32
    0.77

    Return on Equity

    19%

    6%

    You might also like